David Evans
Chief Tech/Sci/R&D Officer at SIRNAOMICS LTD.
Net worth: 67 250 $ as of 2024-04-29
David Evans active positions
Companies | Position | Start | End |
---|---|---|---|
SIRNAOMICS LTD. | Director/Board Member | 2021-07-11 | - |
Chief Tech/Sci/R&D Officer | 2021-07-11 | - | |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2006-12-31 | - |
Founder | 2006-12-31 | - | |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Director/Board Member | 2008-03-09 | - |
Chief Tech/Sci/R&D Officer | 2008-03-09 | - | |
Founder | 2008-03-09 | - |
Career history of David Evans
Former positions of David Evans
Companies | Position | Start | End |
---|---|---|---|
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Chief Operating Officer | 2012-01-31 | 2012-11-30 |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Director/Board Member | 2016-06-30 | - |
Training of David Evans
Imperial College Business School | Doctorate Degree |
Statistics
International
United States | 4 |
United Kingdom | 2 |
China | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 3 |
Founder | 2 |
Sectoral
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SIRNAOMICS LTD. | Health Technology |
Private companies | 4 |
---|---|
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Commercial Services |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- David Evans
- Experience